Disclosure Of Non-Current Assets Held For Sale And Discontinued Operations [Text Block]

BerGenBio - Filing #5877180

Concept 2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
Disclosure of non-current assets held for sale and discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [abstract]
Disclosure of analysis of single amount of discontinued operations [line items]
Profit (loss) before tax
139,282,000 NOK
190,401,000 NOK
Revenue
848,000 NOK
354,000 NOK
Cash flows from continuing and discontinued operations [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
153,242,000 NOK
225,101,000 NOK
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
3,688,000 NOK
3,055,000 NOK
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities
129,609,000 NOK
224,884,000 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.